(Q39179415)

9 September 2017

title

IL-17 and IL-22 in immunity: Driving protection and pathology (English)

1 reference

9 September 2017

0 references

Kilian Eyerich

1

1 reference

9 September 2017

Valentina Dimartino

series ordinal

2

1 reference

9 September 2017

Andrea Cavani

series ordinal

3

1 reference

9 September 2017

language of work or name

English

0 references

publication date

15 March 2017

1 reference

European Journal of Immunology

9 September 2017

published in

1 reference

9 September 2017

volume

47

1 reference

9 September 2017

issue

4

1 reference

9 September 2017

page(s)

607-614

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

9 September 2017

1 reference

Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

IL-22-producing CD4+ T cells: middle-men between the immune system and its environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

IL-17 in Chronic Inflammation: From Discovery to Targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Functional specialization of interleukin-17 family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

The Th17 family: flexibility follows function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Group 3 innate lymphoid cells (ILC3s): Origin, differentiation, and plasticity in humans and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Activation of neutrophils by autocrine IL-17A-IL-17RC interactions during fungal infection is regulated by IL-6, IL-23, RORγt and dectin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

In vivo induction of cutaneous inflammation results in the accumulation of extracellular trap-forming neutrophils expressing RORγt and IL-17.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Yin-Yang Regulation of RORγt Protein Complex in Th17 Differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Balancing Inflammation: The Link between Th17 and Regulatory T Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Dysregulation of proinflammatory versus anti-inflammatory human TH17 cell functionalities in the autoinflammatory Schnitzler syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Autoimmunity beyond Th17: GM-CSF producing T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

IL-22, not simply a Th17 cytokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Transcription factor c-Maf mediates the TGF-β-dependent suppression of IL-22 production in T(H)17 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Proinflammatory environment dictates the IL-17-producing capacity of human invariant NKT cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Generation of pathogenic T(H)17 cells in the absence of TGF-β signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

IL-22, a Th1 cytokine that targets the pancreas and select other peripheral tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Activation of the aryl hydrocarbon receptor reveals distinct requirements for IL-22 and IL-17 production by human T helper cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Interleukin-17 and innate immunity in infections and chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

IL-17 amplifies human contact hypersensitivity by licensing hapten nonspecific Th1 cells to kill autologous keratinocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

IL-17 induces an expanded range of downstream genes in reconstituted human epidermis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-alpha, Oncostatin M and response to biologic therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Claudins regulate the intestinal barrier in response to immune mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

IL-22: a critical mediator in mucosal host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Anti-apoptotic effect of interleukin-22 on fibroblast-like synoviocytes in patients with rheumatoid arthritis is mediated via the signal transducer and activator of transcription 3 signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Protective and pathological properties of IL-22 in liver disease: implications for viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Mechanisms of interleukin-22's beneficial effects in acute pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Interleukin-22 Promotes Wound Repair in Diabetes by Improving Keratinocyte Pro-Healing Functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Circulating Th17, Th22, and Th1 cells are increased in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Melanocyte antigen triggers autoimmunity in human psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Psoriatic T cells recognize neolipid antigens generated by mast cell phospholipase delivered by exosomes and presented by CD1a

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

AhR modulates the IL-22-producing cell proliferation/recruitment in imiquimod-induced psoriasis mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Genetic variants of the IL22 promoter associate to onset of psoriasis before puberty and increased IL-22 production in T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

The IL-23-IL-17 axis in inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Th17 cytokines regulate osteoclastogenesis in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two-year prospective study (the DAMAGE study cohort).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Interleukin 17 contributes to the chronicity of inflammatory diseases such as rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

IL-17-mediated Bcl-2 expression regulates survival of fibroblast-like synoviocytes in rheumatoid arthritis through STAT3 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Role of interleukin 17 in arthritis chronicity through survival of synoviocytes via regulation of synoviolin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Anti-IL-17 therapy in treatment of rheumatoid arthritis: a systematic literature review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Increased frequencies of Th22 cells as well as Th17 cells in the peripheral blood of patients with ankylosing spondylitis and rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Proinflammatory role of the Th17 cytokine interleukin-22 in collagen-induced arthritis in C57BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Loss of IL-22 inhibits autoantibody formation in collagen-induced arthritis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

21 January 2018

IL-23/IL-17 axis in IBD.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

A protective function for interleukin 17A in T cell-mediated intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Differential Roles for Interleukin-23 and Interleukin-17 in Intestinal Immunoregulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Role of the gut microbiota in immunity and inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

IL-17 in atopic eczema: linking allergen-specific adaptive and microbial-triggered innate immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

An asthma-associated IL4R variant exacerbates airway inflammation by promoting conversion of regulatory T cells to TH17-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Th17 regulating lower airway disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

IL-22 contributes to TGF-β1-mediated epithelial-mesenchymal transition in asthmatic bronchial epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Severe atopic dermatitis is characterized by selective expansion of circulating TH2/TC2 and TH22/TC22, but not TH17/TC17, cells within the skin-homing T-cell population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Interleukin-17 and interleukin-22 promote tumor progression in human nonmelanoma skin cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Th17 cells in cancer: help or hindrance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

The role of interleukin 17 in tumour proliferation, angiogenesis, and metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Tumor-specific Th17-polarized cells eradicate large established melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

T helper 17 cells promote cytotoxic T cell activation in tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

The role of the IL-22/IL-22R1 axis in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

High expression of interleukin-22 and its receptor predicts poor prognosis in pancreatic ductal adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Increased intratumoral IL-22-producing CD4(+) T cells and Th22 cells correlate with gastric cancer progression and predict poor patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

Elevated serum IL-22 levels correlate with chemoresistant condition of colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

STATs in cancer inflammation and immunity: a leading role for STAT3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

7 January 2021

TGF-beta indirectly favors the development of human Th17 cells by inhibiting Th1 cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

7 January 2021

IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

7 January 2021

IL-23-mediated psoriasis-like epidermal hyperplasia is dependent on IL-17A

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

7 January 2021

Serum and synovial fluid levels of interleukin-17 in correlation with disease activity in patients with RA

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

7 January 2021

Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

7 January 2021

Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

7 January 2021

High expression of IL-22 suppresses antigen-induced immune responses and eosinophilic airway inflammation via an IL-10-associated mechanism

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

7 January 2021

IL-22 suppresses IFN-γ-mediated lung inflammation in asthmatic patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646723

7 January 2021

Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling

1 reference

31 May 2024

https://opencitations.net/index/api/v1/citations/10.1172/JCI40202

IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis

1 reference

31 May 2024

https://opencitations.net/index/api/v1/citations/10.1172/JCI33194

Identifiers

DOI

10.1002/EJI.201646723

1 reference

9 September 2017

1 reference